Chemical Structure (Buprenorphine 01)
Buprenorphine And Naloxone Tablet
Product Images NDC 72162-1347
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 72162-1347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Buprenorphine 02)
Image (Buprenorphine 03)
Label (Lbl721621347)
This text provides information about a medication in sublingual tablet form containing buprenorphine hydrochloride and naloxone. Each tablet contains 8.62 mg of buprenorphine hydrochloride (equivalent to 8 mg buprenorphine base) and 2.44 mg of naloxone hydrochloride dihydrate (equivalent to 2 mg naloxone base). The tablets are identified by being debossed with "RP" on one side and "n8" on the other side. The medication should be stored at 20° to 25°C (68° to 77°F). The text also emphasizes the importance of ensuring tablets carry both buprenorphine and naloxone. Additionally, it includes guidance for pharmacists, a reminder to keep the product out of the reach of children, and a caution that children who accidentally take the medication will require emergency medical care.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
